rs141381896

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005198.5(CHKB):​c.983A>G​(p.Gln328Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00471 in 1,614,094 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0033 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 23 hom. )

Consequence

CHKB
NM_005198.5 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: -0.178

Publications

7 publications found
Variant links:
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036141276).
BP6
Variant 22-50579775-T-C is Benign according to our data. Variant chr22-50579775-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 128730.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00335 (510/152306) while in subpopulation SAS AF = 0.00663 (32/4828). AF 95% confidence interval is 0.00491. There are 1 homozygotes in GnomAd4. There are 231 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 23 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005198.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHKB
NM_005198.5
MANE Select
c.983A>Gp.Gln328Arg
missense
Exon 9 of 11NP_005189.2
CHKB-CPT1B
NR_027928.2
n.1201A>G
non_coding_transcript_exon
Exon 9 of 30

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHKB
ENST00000406938.3
TSL:1 MANE Select
c.983A>Gp.Gln328Arg
missense
Exon 9 of 11ENSP00000384400.3Q9Y259-1
CHKB
ENST00000481673.5
TSL:1
n.1433A>G
non_coding_transcript_exon
Exon 8 of 10
CHKB
ENST00000939160.1
c.1064A>Gp.Gln355Arg
missense
Exon 10 of 12ENSP00000609219.1

Frequencies

GnomAD3 genomes
AF:
0.00338
AC:
515
AN:
152186
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00724
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00536
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00410
AC:
1021
AN:
248986
AF XY:
0.00427
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.00318
Gnomad ASJ exome
AF:
0.00338
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000972
Gnomad NFE exome
AF:
0.00559
Gnomad OTH exome
AF:
0.00539
GnomAD4 exome
AF:
0.00485
AC:
7090
AN:
1461788
Hom.:
23
Cov.:
32
AF XY:
0.00496
AC XY:
3604
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33480
American (AMR)
AF:
0.00309
AC:
138
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00264
AC:
69
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00624
AC:
538
AN:
86258
European-Finnish (FIN)
AF:
0.00139
AC:
74
AN:
53332
Middle Eastern (MID)
AF:
0.00884
AC:
51
AN:
5768
European-Non Finnish (NFE)
AF:
0.00527
AC:
5856
AN:
1111996
Other (OTH)
AF:
0.00545
AC:
329
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
440
880
1319
1759
2199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
214
428
642
856
1070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00335
AC:
510
AN:
152306
Hom.:
1
Cov.:
32
AF XY:
0.00310
AC XY:
231
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41546
American (AMR)
AF:
0.00248
AC:
38
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4828
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00536
AC:
365
AN:
68034
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00484
Hom.:
9
Bravo
AF:
0.00333
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00616
AC:
53
ExAC
AF:
0.00407
AC:
494
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.00742
EpiControl
AF:
0.00676

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
1
1
Megaconial type congenital muscular dystrophy (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
4.8
DANN
Benign
0.70
DEOGEN2
Benign
0.10
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.11
T
M_CAP
Benign
0.0054
T
MetaRNN
Benign
0.0036
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L
PhyloP100
-0.18
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-0.62
N
REVEL
Benign
0.042
Sift
Benign
0.53
T
Sift4G
Benign
0.53
T
Polyphen
0.0
B
Vest4
0.14
MVP
0.29
ClinPred
0.00058
T
GERP RS
-3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.096
gMVP
0.22
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141381896; hg19: chr22-51018204; API